is semaglutide tirzepatide Addressing the Weight Loss Injectable Shortage: Exploring Compounded and – Skippack Pharmacy Comparative safety and side effects

Patients should note the date and time of application to maintain an accurate schedule

Weiss wrote in a caption: "The biggest thing I've noticed since taking retatrutide is the fact that it's a challenge to actually gain fat not gain weight, but gain body fat." Becerra ("not a bodybuilder by any means at all, but I do like to look good with my shirt off") bought himself a substance labeled "retatrutide" online, a powder mixed with water, and injected it into his muscles with a syringe, just as Weiss and other bodybuilders online described

The risk of DKA is dependent on the dose, and is also less in people with overweight and higher doses of insulin, Mathieu explained

Tirzepatide vs Semaglutide: Side Effects and Tolerability Comparison Common Side Effects for Both Medications The side effect profiles are remarkably similar between the two medications, with gastrointestinal effects being most common: Most Frequent (affecting 10-40% of users): Nausea (typically worst in first 4-8 weeks) Diarrhea or constipation Vomiting (less common than nausea) Abdominal pain or discomfort Decreased appetite (desired effect for weight loss) Less Common (affecting 5-10% of users): Fatigue or tiredness Headache Dizziness Acid reflux or heartburn Burping or gas Management Strategies: Start with lowest dose and increase gradually Eat smaller, more frequent meals Avoid fatty or spicy foods initially Stay well hydrated Take medication at consistent times Serious But Rare Side Effects Both medications carry similar warnings for: Pancreatitis : Severe abdominal pain requiring immediate medical attention Gallbladder problems : May require surgical intervention in some cases Kidney injury : Particularly if severe dehydration occurs Thyroid C-cell tumors : Based on animal studies, human risk unclear Severe allergic reactions : Rare but requires immediate medical care Diabetic retinopathy complications : In patients with existing eye disease Practical Considerations for Patients Dosing and Administration Tirzepatide dosing schedule: Start: 2.5mg weekly for 4 weeks (initiation dose) Increase: 5mg weekly for 4 weeks Further increases: Can go to 10mg then 15mg based on response and tolerability Maintenance: Most patients maintain on 10-15mg weekly Semaglutide dosing schedule: Start: 0.25mg weekly for 4 weeks (Wegovy) or 0.5mg (Ozempic) Gradual increases every 4 weeks Maximum: 2.4mg weekly for weight loss, 2.0mg for diabetes Cost and Insurance Considerations Cost remains a significant factor for many patients

Tirzepatide pens are for single use only and should be discarded after one injection